Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
43M
-
Shares change
-
+3.05M
-
Total reported value, excl. options
-
$488M
-
Value change
-
+$35.4M
-
Put/Call ratio
-
0.33
-
Number of buys
-
66
-
Number of sells
-
-35
-
Price
-
$11.34
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2018
122 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q2 2018.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43M shares
of 114M outstanding shares and own 37.64% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (6.66M shares), FMR LLC (6.63M shares), FRANKLIN RESOURCES INC (5.53M shares), BlackRock Inc. (3.29M shares), Casdin Capital, LLC (2.6M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), VANGUARD GROUP INC (2.17M shares), STATE STREET CORP (1.99M shares), Artal Group S.A. (1.7M shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (805K shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.